Clinical Trials
2 trialsNCT04807972 2025-01-07
Study to Evaluate Adverse Events and Change in Disease Activity When Intravenous (IV) Infusion of ABBV-927 is Administered in Combination With IV Modified FOLFIRINOX (mFFX) With or Without IV Budigalimab Compared to mFFX in Adult Participants With Untreated Pancreatic Cancer Metastasis
AbbVie
Phase 1 Terminated
NCT03035279 2020-02-20
A Study of SC-006 and in Combination With ABBV-181 in Subjects With Advanced Colorectal Cancer
AbbVie
Phase 1 Terminated